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ABSTRACT 
The multidrug resistance (mdrl) gene product, P- 
glycoprotein, is responsible for the ATP-dependent 
extrusion of a variety of compounds, including chemo- 
therapeutic drugs, from cells. The data presented here 
show that cells with increased levels of the P-glyco- 
protein release ATP to the medium in proportion to the 
concentration of the protein in their plasma mem- 
brane. Furthermore, measurements of whole-cell and 
single-channel currents with patch-clamp electrodes 
indicate that the P-glycoprotein serves as an ATP- 
conducting channel in the plasma membrane. These 
findings suggest an unusual role for the P-glycoprotein. 
COMMENTS 
The multidrug resistance (MDR) phenomenon exem- 
plifies how molecular biology can identify genes and 
protein sequences before the specific protein has been 
purified and sequenced. The MDR phenomenon involves 
resistance of cancer cells to a group of anticancer agents 
that do not, superficially at least, share common 
structure. The phenotype results from overexpression of 
a family of transmembrane proteins of approximately 
170 kD, which were initially identified after labeling by 
affinity probes of anticancer drugs. Victor Ling of the 
Ontario Cancer Center discovered MDR proteins and 
presciently called them “P-glycoprotein,” on the basis of 
the hypothesis that altered cell permeability to anti- 
cancer drugs was responsible (1). Subsequent studies 
revealed that MDR gene products code for 170-kD mem- 
brane glycoproteins, which by hydropathy analysis, span 
the plasma membrane 12 times and have 2 nucleotide- 
binding sites and were postulated to function as ATP- 
dependent efflux pumps (2). Cells that overexpress MDR 
gene products pump hydrophobic cationic drugs, such as 
vinblastine, daunomycin and others, out of the cell pre- 
sumably faster than the compounds can interact with 
vital cell machinery and exert their anticancer effects. 
Much support exists for this hypothesis: (a) MDR-ex- 
pressing cancer cells are drug resistant and rapidly efflux 
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anticancer drugs; (b) transfection of the MDRl gene into 
naive cells produces an MDR phenotype and expression 
of a 170-kD membrane P-glycoprotein; and (c) kinetic 
studies of drug-sensitive and MDR-related resistant cell 
lines indicat,e that the former pump anticancer drugs out 
faster than do the latter. 
Nevertheless, uncertainties have surfaced about how 
P-glycoproteins function. Why should a cell use ATP to 
efflux relatively hydrophobic molecules that can readily 
return to the cell by nonionic diffusion? P-glycoprotein 
substrates are neither chemically modified nor rendered 
hydrophilic, and no downstream binding molecule exists 
to retain them extracellularly. Their detection in the 
apical domain of several polarized normal cells prompts 
inquiry into a potential natural substrate or substrates. 
One hypothesis is that cells use ATP to prevent for- 
mation of potentially transforming or damaging DNA 
adducts from naturally occurring hydrophobic pesti- 
cides. We tend to think that pesticides were invented by 
the chemical industry and neglect the fact that every 
plant protects itself by a host of such molecules. 
If P-glycoproteins function as specific efflux pumps, a 
direct relation should be found between the amount of 
P-glycoprotein in a cell and the initial rate of substrate 
efflux. Rigorous testing of this type has not been 
performed. Many studies reveal that cells that overex- 
press P-glycoprotein transport more substrate than do 
control cells; however, one recent study found no 
relation betaween the initial efflux rate and P-glyco- 
protein content (3). Cells that expressed the highest 
levels of P-glycoprotein had increased intracellular pH, 
which suggests that drug efflux may be caused by proton 
movement! This association was not observed in another 
study but requires further investigation. 
Clinical interest in reversing anticancer drug resis- 
tance has prompted study of many potential drugs and 
chemicals that may block the MDR phenotype. Ve- 
rapamil, cyclosporine and a few other compounds appear 
to be competitive inhibitors; however, it is not known in 
most studies whether the potential reversing agent is a 
substrate for P-glycoprotein. Hydrophobic bile acids, 
hormones and drugs block the MDR phenotype noncom- 
petitively and are not substrates for the P-glycoprotein 
transport function. Whether these compounds will 
prove to have clinical value in treating drug-resistant 
cancer patients remains to be determined. 
At the structural and molecular level, other consider- 
ations pertain regarding how P-glycoprotein functions 
as a transporter. Comparison of the derived sequence of 
P-glycoproteins with sequence data banks revealed 
similarities with a wide variety of membrane trans- 
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porters in yeast, bacteria, plasmodia and other parasites, 
as well as cystic fibrosis transport receptor (CFTR), the 
cystic fibrosis gene product. Major homology and in 
some cases identity were demonstrated in the two 
nucleotide-binding domains and overall topology of the 
12 membrane-spanning domains. Recent studies in- 
dicate that P-glycoprotein also functions as a chloride 
channel (3). Cellular hypotonicity activates the chloride 
channel function. Transportable drugs prevent channel 
activation but not preactivation. The transport and 
channeI functions of P-glycoprotein were separated by 
mutations in the nucleotide-binding domains of the 
protein (4). Thus P-glycoprotein appears to be a bifunc- 
tional protein with both ion channel and transport 
activities. In  situ hybridization studies with probes for 
CFTR and P-glycoprotein reveal that the two genes have 
complementary patterns of expression; this finding 
suggests that CFTR and P-glycoprotein may serve 
similar roles in epithelial cells and provides additional 
evidence that P-glycoprotein may regulate cell volume 
(5 ) .  
Abraham et al. now provide electrophysiological evi- 
dence that P-glycoprotein may function as an ATP 
channel. They emphasize that the mechanism of 
transport is not known for any member of the ATP- 
binding cassette superfamily . Using patch-clamp tech- 
nique, they demonstrated that cells release ATP in direct 
relation to the relative level of P-glycoprotein. These 
provocative studies do not demonstrate that P-glyco- 
protein transports ATP, but the association suggests 
this as a likely hypothesis. In an abstract presented at 
the annual meeting of the Society of General Physiolo- 
gists, these investigators also report that expression of 
CFTR results in appearance of an ATP channel (6). 
Perhaps all ATP-binding cassette transporters primarily 
transport ATP, and the other substrates (i.e., hydro- 
phobic drugs and chloride) are secondary. Further 
studies are required to demonstrate a direct relation 
between ATP secretion and P-glycoprotein including 
reconstitution studies. However, the hypothesis that 
these studies generate is provocative. ATP has long been 
considered to be restricted to the intracellular domain. 
Studies in many cell types indicate that ATP can be 
extracellular and also a neurotransmitter. Purinergic 
receptors of several types have been identified on neural 
and epithelial cells and function in signal transduction. 
Many epithelial and endothelial cells contain abun- 
dant calcium-magnesium ecto-ATPase and AMPase ac- 
tivities that hydrolyze ATP to ADP, AMP and eventually 
to adenosine (7). Sodium-dependent adenosine trans- 
porters have been demonstrated in the apical domain of 
hepatocytes, small intestinal mucosal and proximal 
tubular cells. In vitro, right-side-out canalicular mem- 
brane vesicle preparations rapidly hydrolyze ATP, and 
the resulting adenosine is transported into the vesicle 
(8). Do ATP-binding cassette transporters function in a 
similar manner? Are they related to naturally occurring 
homologs that secrete ATP and form adenosine that is 
then conserved? Not all cells can make adenosine, which 
is critical for many cellular functions. We are not used to 
thinking of ATP as a secretory modality; traditional 
concepts concern the energy expended in making ATP 
and utilization of the stored energy to drive metabolic 
processes and ion pumps. The studies of Abraham et al. 
raise provocative and fundamental questions. 
In normal liver, P-glycoproteins are restricted to the 
bile canalicular domain of the plasma membrane (9). 
The major gene product results from mdr2, which does 
not confer multidrug resistance after transfection (10). 
The substrate for mdr2 is not known. Other newly 
described canalicular ATP-dependent transport systems 
involve bile acids and non-bile acid organic anions (11, 
12). The relation, if any, between these systems and ATP 
transport remains to be determined. 
The multidrug-resistant genes and their products 
provide an exciting arena for the interface of biology, 
transformation, drug-resistance and transport. The 
novel hypothesis regarding their mechanism and 
function provides a challenge for experimental study. 
Much remains to be learned and applied to human 
physiology and disease. 
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